Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S K Khaled
A Phase II Study of Sirolimus, Tacrolimus and Rabbit Anti-Thymocyte Globulin as GVHD Prophylaxis After Unrelated-Donor PBSC Transplant
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Efficacy of Rabbit Anti-Thymocyte Globulin in Severe Aplastic Anemia
Haematologica
Hematology
Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) With Tacrolimus and Methotrexate (Tac/Mtx) GVHD Prophylaxis in Patients With AML Undergoing Transplantation From Matched Related or Unrelated Donors
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Decreased Insulin Secretion in Patients Receiving Tacrolimus as GVHD Prophylaxis After Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation Combined With Unrelated Cord Blood for Patients With Hematologic Malignancies: A Prospective, Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Cell Transplantation After Failed Autologous Transplant for Lymphoma Using TLI and Anti-Thymocyte Globulin Conditioning
Bone Marrow Transplantation
Transplantation
Hematology
Beneficial Impact of Low-Dose Rabbit Anti-Thymocyte Globulin in Unrelated Hematopoietic Stem Cell Transplantation: Focusing on Difference Between Stem Cell Sources
Bone Marrow Transplantation
Transplantation
Hematology
Predictors of Overall Survival Among Patients Treated With Sirolimus/Tacrolimus vs Methotrexate/Tacrolimus for GvHD Prevention
Bone Marrow Transplantation
Transplantation
Hematology
Visilizumab With Tacrolimus and Methotrexate for GvHD Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
Bone Marrow Transplantation
Transplantation
Hematology
